Tarsus Pharmaceuticals, Inc. TARS Return on invested capital

Return on invested capital at other companies

AbbVieABBV

17.1%—

Bausch + LombBLCO

2.9%+2.6pp

HRO

HarrowHROW

5.7%+4.4pp

EyePoint, Inc.EYPT

-228.9%-1,528pp

Regeneron PharmaceuticalsREGN

10.3%-1.5pp

Warby ParkerWRBY

0.5%+0.2pp

FAQ

What is Tarsus Pharmaceuticals, Inc.'s return on invested capital?

Tarsus Pharmaceuticals, Inc. (TARS) reported return on invested capital of -18.2% in Q2 2026.

How has Tarsus Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s return on invested capital increased by 58.3% year-over-year, from -43.5% to -18.2%.

What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s return on invested capital?

Over 2 years (2023 to 2025), Tarsus Pharmaceuticals, Inc.'s return on invested capital has grown at a -59.5% compound annual growth rate (CAGR), from -197% to -32.3%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.